The experimental results show that the PI3K/AKT/mTOR signaling pathway is inhibited by miR497/TP-HENPs-treated ovarian cancer cells, which reduces the expression of anti-apoptotic proteins, such as Bcl-2 and Bcl-XL, promotes apoptosis and overcomes cell drug resistance. Here, MTOR is linked to ovarian carcinoma.